Ray Therapeutics

Berkeley, CA · Founded 2021 · Privately Held (backing)

Developer of optogenetic gene therapies designed for vision restoration purposes. Ray Therapeutics is based in Berkeley, CA and was founded in 2021. It has raised $106 million across 2 recorded rounds; the latest was a $14 million early-stage round in May 2023.

Last price · $/share
—
Implied valuation
—
Total raised
$106.0M
Last round
Early Stage VC
May 2023
No prints on record

No secondary trades in Ray Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ray Therapeutics with a free account
  • ·Watch Ray Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Ray Therapeutics prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Ray Therapeutics stock.